COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD.

Hamish Joseph Cameron McAuleyKate HadleyOmer ElneimaChristopher E BrightlingRachael Andrea EvansMichael C SteinerNeil J Greening

Published in: ERJ open research (2021)

Treatment for AECOPD events increased during the first 6 weeks of the SARS-CoV-2 pandemic in the UK compared with 2019. This was associated with increased symptoms of anxiety and significant behavioural change.

Keyphrases

sars cov
chronic obstructive pulmonary disease
coronavirus disease
respiratory syndrome coronavirus
lung function
liver failure
cystic fibrosis
sleep quality
respiratory failure
drug induced
aortic dissection
depressive symptoms
extracorporeal membrane oxygenation